thalidomide and hydroxyurea

DRUG2 trials

Sponsors

Blood Diseases Clinic, National Institute of Blood and Marrow Transplant (NIBMT), Pakistan

Conditions

Beta-ThalassemiaFetal HemoglobinHemoglobinopathiesThalassemia

Phase 2

Efficacy and Safety of Low Dose Thalidomide in Transfusion Dependent Thalassemia

CompletedNCT03651102

Blood Diseases ClinicThalassemia

Start: 2018-01-01End: 2022-03-01Updated: 2022-03-25

Long Term Beta Thalassemia Treatment: Findings From The Extension Period

Active, not recruitingNCT06490601

National Institute of Blood and Marrow Transplant (NIBMT), PakistanBeta-Thalassemia, Fetal Hemoglobin, Hemoglobinopathies

Start: 2022-04-01End: 2025-07-01Target: 30Updated: 2025-05-30

Related Papers

Long-term clinical efficacy and safety of thalidomide in patients with transfusion-dependent β-thalassemia: results from Thal-Thalido study

Scientific Reports2023-08-2116 citations